https://www.selleckchem.com/GSK-3.html
emergent; 3.695, P 0.001) were associated with therapeutic efficacy, while the furosemide dose (0.280 per +20mg/day, P = 0.014) and previous ascites-related events (0.074, P 0.001) were associated with the long-term outcome. Receiver operating curve analyses identified the optimal cut-off values for the furosemide dose as 15mg/day (P 0.001). Furthermore, the cumulative survival rates in patients receiving furosemide at 15mg/day or less were significantly higher than those in the remaining patients (P = 0.048). Furosemide given at ba